@inbook{a130c775ca3947e5b3cd80e14347c3cb,
title = "Copper biology",
abstract = "This annex describes the copper in biosystems, namely copper proteins and copper interactions with biomolecules and human diseases. Copper transport and metabolic diseases can be diagnosed or followed up in the future using CuCl2 radiopharmaceutical in human clinical trials. Although most of the copper proteins covered in this annex are important and active in non‑human biological systems, the significant role of copper in organisms can also be investigated by the application of the 64Cu radionuclide for basic biological and biochemical research.",
author = "Fedor Zhuravlev",
year = "2022",
language = "English",
isbn = "978–92–0–129621–4",
series = "IAEA Radioisotopes and Radiopharmaceuticals Series",
number = "7",
pages = "98--110",
booktitle = "Copper-64 Radiopharmaceuticals; Production, Quality Control and Clinical Applications",
publisher = "International Atomic Energy Agency",
}
